Company Analysis
Sign in

Organigram Global Inc. (OGI)

Nasdaq: OGI · Pharmaceutical Preparations · Toronto · filing with the SEC since 2015
Full chart Alerts Compare
Grade5.5
◀ Past 7.1● Present 5.5▶ Future 4.1
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2024, as filed
RevenueC$160M+9.6%
Net income-C$45.4M-218.1%
Earnings per shareC$-0.48-159.2%
Operating cash flowC$3.9M+110.7%
Cashn/a
DebtC$25,000-83.9%
Shareholders’ equityC$306M+12.7%
Shares, diluted95.3M+23.4%
Return on equity-14.8%
The recordfrom its filings
Filings in 202630
Newest filingNov 13 · 6-K
Annual reportDec 16, 2025
Quarterly reportn/a
Next report due40-F by Jan 28
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer category<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
181920212224
As filed, in CAD. Nothing here is a forecast.

News

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton OGI · research, not advice